Guest User Icon

Welcome Guest User

banner

Home > Leukemia Cancer

  • Overview
  • Symptoms
  • Risk Factor
  • Diagnosis
  • Our Offerings

Overview

Acute Lymphoblastic Leukemia (ALL) is a type of cancer that affects the blood and bone marrow, a semi-solid tissue found within the spongy or cancellous portions of bones, where blood cells are produced.
Acute myeloid leukemia (AML) is a rapidly progressing blood cancer that affects the bone marrow. It is characterized by the production of abnormal white blood cells, which crowd out healthy blood cells.

Incidence

  • bullet-point-icon
    Leukemia (more than 95% of which is acute) is the most common diagnostic group of childhood cancers worldwide and in India.
  • bullet-point-icon
    Risk for developing Acute Lymphoblastic Leukemia is highest among children less than 5 years.
  • bullet-point-icon
    The risk declines steadily until the mid-20s, and starts rising again steadily after the age of 50 years.

Signs and symptoms of Acute Lymphoblastic Leukemia may include

Signs and symptoms of Acute Lymphoblastic leukemia may include
Bleeding-such-as-frequent

Bleeding, such as frequent or severe nosebleeds, bleeding gums, or heavy menstrual bleeding in women

Fever-Bone-pain

Fever, bone pain and frequent infections

Pale-skin

Pale skin and shortness of breath

Leukemia-cells

Leukemia cells may build up in the liver and spleen, thereby enlarging these organs.

Weakness

Weakness, fatigue or a general decrease in energy

Risk Factor

A risk factor is something that increases your chance of getting a disease such as cancer. Some risk factors, like smoking, can be controlled. Others, like a person's age or family history, can't be controlled
Patient-Centric Approach

Ethnicity

More common in Caucasians, reasons not clear.

Gender

Gender

Slightly more prevalent in males than in females, reasons unknown

Risk-5

Exposure to Radiation

High levels of radiation exposure is a risk factor for both Acute Lymphoblastic Leukemia (ALL) and Acute Myeloid Leukemia (AML). E.g.: Atomic bomb survivors of Japan had increased risk of developing acute Leukemia.

Reports Disbursal

Chemical Exposure

Some chemotherapy drugs and certain other chemicals, like benzene may increase the risk to Acute Lymphoblastic Leukemia.

Age

Age

More likely to occur in children < 5 years and in adults over the age of 50 years.

Diagnosis

Bone-Marrow-Tests

Bone Marrow Tests

Bone Marrow Aspiration

Samples are usually taken from the back of the pelvic (hip) bone, although in some cases they may be...

Biopsy

Biopsy

Lumbar Puncture (Spinal Tap)

Acute Leukemia can spread to the area around the brain and spinal cord. To check for this spread, do...

Lymph-Node-Biopsy

Lymph Node Biopsy

A lymph node or part of a lymph node is often removed to help diagnose lymphomas, but this is only r...

Lab-Tests-Used-to-Diagnose

Lab Tests Used to Diagnose And Classify ALL

Cytochemistry

Cytochemistry is part of lab tests used to diagnose and classify leukemia. Cells are put on a slide ...

Blood-Tests

Blood Tests

Complete Blood Count (CBC)

measures the numbers of RBCs, WBCs, and platelets. It is often done along with a differential which ...

Viral-Screening-Tests

Viral Screening Tests

Physical-Exam

Physical Exam and History

Imaging-Tests

Imaging Tests

Our Offerings

  • Clinical Work up
  • Department

Diagnostic work up

t(9;11) (p21-22;q23); (MLL-AF9) PCR QUALITATIVE

CANCER 50 GENE PANEL, NGS

CANCER GENE ANY 3 MARKERS, NGS

CHROMOSOME ANALYSIS FOR HEMATOLOGIC MALIGNANCY

FISH: BCR / ABL OR PHILADELPHIA TRANSLOCATION

FISH: 11q23 OR LSI MLL GENE BREAKAPART

FISH: t(12;21) or LSI TEL/AML1

COMPLETE BLOOD COUNT; CBC

IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL ACUTE LEUKEMIA -T, B or MYELOID

BONE MARROW EXAMINATION PANEL 1

BONE MARROW EXAMINATION PANEL 2

IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC PANEL CUSTOMIZED ANY 10 MARKERS

LEUKEMIA GENETIC PROFILE - ANY 6 MARKERS PCR QUALITATIVE

IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE ANY 6 MARKERS

BCR-ABL GENE REARRANGEMENT PCR QUANTITATIVE

BCR-ABL GENE REARRANGEMENT PCR QUALITATIVE

t(1;19) (q23;p13.3); TCF3- BX1(E2A-PBX1) PCR QUALITATIVE

t(12;21) (p13;q22); ETV6-RUNX1 (TEL-AML1) PCR QUALITATIVE

t(4;11) (q21;q23); (MLL-AF4) PCR QUALITATIVE

t(11;19) (q23;p13.3); (MLL-ENL) PCR QUALITATIVE

Follow up

IMMUNOPHENOTYPING BY FLOW CYTOMETRY, CD34 (STEM CELL) ENUMERATION

CANCER 50 GENE PANEL, NGS

MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR B- ALL

MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR T-ALL

Prognostic work up

BCR-ABL GENE REARRANGEMENT PCR QUANTITATIVE

BCR-ABL GENE REARRANGEMENT PCR QUALITATIVE

t(1;19) (q23;p13.3); TCF3- BX1(E2A-PBX1) PCR QUALITATIVE

t(12;21) (p13;q22); ETV6-RUNX1 (TEL-AML1) PCR QUALITATIVE

t(4;11) (q21;q23); (MLL-AF4) PCR QUALITATIVE

t(11;19) (q23;p13.3); (MLL-ENL) PCR QUALITATIVE

t(9;11) (p21-22;q23); (MLL-AF9) PCR QUALITATIVE

CANCER 50 GENE PANEL, NGS

CANCER GENE ANY 3 MARKERS, NGS

CHROMOSOME ANALYSIS FOR HEMATOLOGIC MALIGNANCY

FISH: BCR / ABL OR PHILADELPHIA TRANSLOCATION

FISH: 11q23 OR LSI MLL GENE BREAKAPART

LEUKEMIA GENETIC PROFILE - ANY 6 MARKERS PCR QUALITATIVE

IMMUNOPHENOTYPING BY FLOW CYTOMETRY: LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE ANY 6 MARKERS

ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CYTOGENETICS PANEL

ACUTE LEUKEMIA DIAGNOSTIC COMPREHENSIVE PROFILE

Screening

HTLV - I / II ANTIBODY, SCREEN

HTLV - I / II ANTIBODY CONFIRMATION

EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN (VCA), IgG

EPSTEIN-BARR VIRUS ANTIBODY TO VIRAL CAPSID ANTIGEN (VCA), IgM

EPSTEIN BARR VIRUS ANTIBODIES TO VIRAL CAPSID ANTIGEN (VCA), IgG & IgM

NEUROVIRUSES COMPREHENSIVE PANEL QUALITATIVE PCR

EPSTEIN BARR VIRUS (EBV), QUALITATIVE PCR

EPSTEIN BARR VIRUS (EBV), QUANTITATIVE PCR

Are you an Oncologist

Are you an Oncologist

Get in touch arrow
Are you a Patient

Are you a Patient or a Family Member of a Patient?